2021 European Society for Gene and Cell Therapy (ESGCT) Congress

Oct 22 2021
Abstract Title: Multicentre, prospective research protocol for development of a clonal neoantigen-reactive T cell therapy pipeline across multiple tumour types
Presentation Number: OR54
Session: 6c Manufacturing
Session Time: Friday, October 22, 2021: 9:00am–11:00am CEST (3:00am–5:00am ET)
Presenter: Michael Grant, MB, BCh, BAO, BSc, PGCert, FHEA, Associate Medical Director, Achilles Therapeutics
Print Page
RSS Feeds
Email Alerts
Contact IR